OCT 27, 2026 · JOURNAL ARTICLE
EARLY CHEMOTHERAPY-INDUCED NEUTROPENIA AS A PREDICTOR OF TUMOR RESPONSE IN BREAST CANCER PATIENTS RECEIVING NEOADJUVANT CHEMOTHERAPY
Practical Surgery
Background. Neoadjuvant chemotherapy (NACT) is an essential component of comprehensive treatment for locally advanced and biologically aggressive breast cancer. However, individual